Company news

Wave Life Sciences Ltd. news in 2021

Wave Life Sciences Ltd.'s news releases, calls and decks from 2021, newest first.

View company

Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

November 9, 2021

Wave Life Sciences to Present at the Stifel 2021 Virtual Healthcare Conference

November 7, 2021

Wave Life Sciences to Webcast Conference Call of Third Quarter 2021 Financial Results on November 10, 2021

October 31, 2021

Wave Life Sciences and Takeda Amend CNS Collaboration

October 17, 2021

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy

September 28, 2021

Wave Life Sciences Announces New Data for Leading RNA Editing Capability Across Multiple Tissues and Provides Update on AATD Program During Analyst and Investor Research Webcast

September 27, 2021

Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference

September 21, 2021

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease

September 8, 2021

Wave Life Sciences to Highlight RNA Editing Capability and AATD and Neurology Programs at 2021 Analyst and Investor Research Webcast on September 28, 2021

September 7, 2021

Wave Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 6, 2021

Wave Life Sciences to Highlight RNA Editing Modality and PRISM Platform Advancements During Upcoming Scientific Conferences

September 6, 2021

Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update

August 4, 2021

Wave Life Sciences to Webcast Conference Call of Second Quarter 2021 Financial Results on August 5, 2021

July 25, 2021

Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a FOCUS-C9 Clinical Trial of WVE-004 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

July 19, 2021

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency

June 1, 2021

Wave Life Sciences to Present at Jefferies Virtual Healthcare Conference

May 27, 2021

Wave Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update

May 12, 2021

Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference

May 9, 2021

Wave Life Sciences to Webcast Conference Call of First Quarter 2021 Financial Results on May 13, 2021

May 2, 2021

Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials

March 28, 2021

Wave Life Sciences to Present at the Third Annual Stifel CNS Day

March 18, 2021

Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

March 3, 2021

Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

February 22, 2021

Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference

February 15, 2021

Wave Life Sciences Highlights Pipeline Progress and Expansion Leveraging New PN Backbone Chemistry Modifications

January 10, 2021

Calls in 2021

Decks in 2021